Our top pick for
eHealth, Inc is an insurance brokers business based in the US. eHealth shares (EHTH) are listed on the NASDAQ and all prices are listed in US Dollars. eHealth employs 1,960 staff and has a trailing 12-month revenue of around USD$582.8 million.
|52-week range||USD$48.54 - USD$151.66|
|50-day moving average||USD$63.5794|
|200-day moving average||USD$71.4756|
|Wall St. target price||USD$67.18|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$1.68|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing eHealth stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of eHealth's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
eHealth's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, eHealth shares trade at around 33x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
eHealth's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.7211. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into eHealth's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
eHealth's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$58.5 million.
The EBITDA is a measure of a eHealth's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$582.8 million|
|Operating margin TTM||9.15%|
|Gross profit TTM||USD$578.7 million|
|Return on assets TTM||3.74%|
|Return on equity TTM||6.66%|
|Market capitalisation||USD$1.5 billion|
TTM: trailing 12 months
There are currently 2.2 million eHealth shares held short by investors – that's known as eHealth's "short interest". This figure is 3.4% down from 2.3 million last month.
There are a few different ways that this level of interest in shorting eHealth shares can be evaluated.
eHealth's "short interest ratio" (SIR) is the quantity of eHealth shares currently shorted divided by the average quantity of eHealth shares traded daily (recently around 2.0 million). eHealth's SIR currently stands at 1.11. In other words for every 100,000 eHealth shares traded daily on the market, roughly 1110 shares are currently held short.
However eHealth's short interest can also be evaluated against the total number of eHealth shares, or, against the total number of tradable eHealth shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case eHealth's short interest could be expressed as 0.08% of the outstanding shares (for every 100,000 eHealth shares in existence, roughly 80 shares are currently held short) or 0.0972% of the tradable shares (for every 100,000 tradable eHealth shares, roughly 97 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against eHealth.
Find out more about how you can short eHealth stock.
We're not expecting eHealth to pay a dividend over the next 12 months.
Over the last 12 months, eHealth's shares have ranged in value from as little as $48.54 up to $151.66. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while eHealth's is -0.2668. This would suggest that eHealth's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, eHealth has bucked the trend.
eHealth, Inc. provides private health insurance exchange services to individuals, families, and small businesses in the United States and China. The company operates through two segments, Medicare; and Individual, Family and Small Business. Its ecommerce platforms organize and present health insurance information in various formats that enable individuals, families, and small businesses to research, analyze, compare, and purchase a range of health insurance plans. The company's Medicare-related health insurance plans include medicare advantage, medicare supplement, and medicare part D prescription drug plans; and ancillary products, including dental, vision, life, and short and long term disability insurance plans. It markets health insurance plans through its websites, such as eHealth.com, eHealthInsurance.com, eHealthMedicare.com, Medicare.com, PlanPrescriber.com, and GoMedigap.com, as well as through a network of marketing partners. The company also licenses its health insurance ecommerce technology that enables health insurance carriers and agents to market and distribute health insurance plans online; and provides online sponsorship and advertising services. eHealth, Inc. was incorporated in 1997 and is headquartered in Santa Clara, California.
Everything we know about the Reddit IPO, plus information on how to buy in.
Everything we know about the Hayward Holdings Inc IPO, plus information on how to buy in.
Everything we know about the Alignment Healthcare Inc IPO, plus information on how to buy in.
Everything we know about the Olink Holding AB (publ) IPO, plus information on how to buy in.
Everything we know about the Procore IPO, plus information on how to buy in.
Everything we know about the Navios South American Logistics Inc IPO, plus information on how to buy in.
Everything we know about the Lava Therapeutics IPO, plus information on how to buy in.
Everything we know about the Pop Culture Group Co Ltd IPO, plus information on how to buy in.
Everything we know about the Bukalapak IPO, plus information on how to buy in.
Everything we know about the Achilles Therapeutics plc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.